LabCorp buys a nutrition testing business; Catalent plans to quadruple Shanghai capacity;

> LabCorp ($LH) acquired Safe Foods International Holdings, a nutritional testing firm, and plans to integrate with Covance, the CRO it bought for about $6 billion this year. More

> Catalent ($CTLT) is planning to quadruple its capacity at a Shanghai clinical supply facility. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.